Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Coumestrol | 2 | 2010 | 5 | 0.630 |
Why?
|
| DDT | 2 | 2010 | 15 | 0.620 |
Why?
|
| Oxides | 2 | 2014 | 89 | 0.550 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2014 | 3 | 0.500 |
Why?
|
| Apoptosis | 9 | 2014 | 1317 | 0.490 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 36 | 0.490 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 72 | 0.480 |
Why?
|
| Glioblastoma | 1 | 2014 | 49 | 0.470 |
Why?
|
| Environmental Pollutants | 2 | 2014 | 166 | 0.470 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 105 | 0.450 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 203 | 0.430 |
Why?
|
| Caspases | 3 | 2008 | 132 | 0.350 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 2 | 2008 | 10 | 0.350 |
Why?
|
| Estrogens | 2 | 2010 | 190 | 0.340 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2008 | 6 | 0.340 |
Why?
|
| Mitochondria | 2 | 2008 | 454 | 0.310 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 968 | 0.300 |
Why?
|
| Interleukin-2 | 1 | 2004 | 87 | 0.240 |
Why?
|
| Phenols | 1 | 2004 | 76 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2010 | 139 | 0.230 |
Why?
|
| Cell Cycle | 5 | 2010 | 309 | 0.210 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 251 | 0.210 |
Why?
|
| Arsenicals | 2 | 2014 | 85 | 0.200 |
Why?
|
| Jurkat Cells | 5 | 2008 | 72 | 0.190 |
Why?
|
| Cell Line | 7 | 2017 | 1289 | 0.180 |
Why?
|
| Peroxiredoxins | 1 | 2017 | 10 | 0.150 |
Why?
|
| Estradiol | 3 | 2005 | 244 | 0.150 |
Why?
|
| Cardiolipins | 2 | 2008 | 11 | 0.150 |
Why?
|
| Cell Proliferation | 2 | 2014 | 1149 | 0.150 |
Why?
|
| Humans | 18 | 2017 | 34853 | 0.140 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 36 | 0.140 |
Why?
|
| RNA Interference | 1 | 2017 | 225 | 0.140 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 32 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 407 | 0.140 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 106 | 0.130 |
Why?
|
| Cell Movement | 2 | 2017 | 545 | 0.130 |
Why?
|
| Lentivirus | 1 | 2014 | 20 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2016 | 229 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 239 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 161 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2016 | 486 | 0.120 |
Why?
|
| DNA Damage | 2 | 2014 | 341 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2014 | 143 | 0.120 |
Why?
|
| Caspase 3 | 3 | 2010 | 194 | 0.120 |
Why?
|
| Cell Survival | 2 | 2014 | 818 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 166 | 0.110 |
Why?
|
| Blotting, Western | 4 | 2010 | 834 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2017 | 386 | 0.110 |
Why?
|
| Hela Cells | 2 | 2010 | 344 | 0.100 |
Why?
|
| Protein Kinase C-delta | 2 | 2008 | 14 | 0.100 |
Why?
|
| Models, Biological | 2 | 2017 | 642 | 0.090 |
Why?
|
| T-Lymphocytes | 2 | 2005 | 341 | 0.090 |
Why?
|
| Cell Line, Tumor | 2 | 2014 | 2128 | 0.090 |
Why?
|
| Enzyme Activation | 2 | 2008 | 423 | 0.090 |
Why?
|
| Transfection | 2 | 2008 | 496 | 0.090 |
Why?
|
| DNA Replication | 1 | 2010 | 148 | 0.090 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 485 | 0.090 |
Why?
|
| Caspase 8 | 1 | 2008 | 31 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 2008 | 31 | 0.080 |
Why?
|
| Protein Binding | 2 | 2017 | 913 | 0.080 |
Why?
|
| Progesterone | 3 | 2003 | 117 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2008 | 168 | 0.080 |
Why?
|
| DNA Primers | 1 | 2008 | 269 | 0.080 |
Why?
|
| Endocytosis | 1 | 2008 | 104 | 0.080 |
Why?
|
| Testosterone | 2 | 2005 | 181 | 0.070 |
Why?
|
| Base Sequence | 1 | 2008 | 932 | 0.070 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 391 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 336 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 325 | 0.070 |
Why?
|
| Endostatins | 1 | 2005 | 5 | 0.070 |
Why?
|
| Lipopolysaccharides | 3 | 2003 | 200 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2005 | 116 | 0.060 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 146 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 781 | 0.060 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 2004 | 17 | 0.060 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 197 | 0.060 |
Why?
|
| Insecticides | 1 | 2004 | 47 | 0.060 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 42 | 0.060 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 8 | 0.060 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 222 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2003 | 24 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 42 | 0.050 |
Why?
|
| Hemin | 1 | 2001 | 5 | 0.050 |
Why?
|
| Tissue Preservation | 1 | 2001 | 7 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2004 | 1152 | 0.050 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2001 | 29 | 0.050 |
Why?
|
| Cyclin A | 1 | 2001 | 5 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2001 | 25 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2004 | 306 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 160 | 0.050 |
Why?
|
| Monocytes | 1 | 2003 | 258 | 0.050 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2001 | 50 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2001 | 181 | 0.050 |
Why?
|
| Signal Transduction | 2 | 2005 | 1802 | 0.050 |
Why?
|
| Transcription, Genetic | 2 | 2001 | 550 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 120 | 0.040 |
Why?
|
| Cytokines | 2 | 2001 | 569 | 0.040 |
Why?
|
| Thymidine | 2 | 2010 | 15 | 0.040 |
Why?
|
| Macrophages | 1 | 2001 | 431 | 0.040 |
Why?
|
| Disulfides | 1 | 2017 | 77 | 0.040 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 13 | 0.040 |
Why?
|
| Protein Transport | 1 | 2017 | 286 | 0.040 |
Why?
|
| Binding Sites | 1 | 2017 | 597 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 484 | 0.030 |
Why?
|
| Disease Progression | 1 | 2016 | 580 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 707 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 964 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 292 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1056 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2005 | 200 | 0.030 |
Why?
|
| Female | 2 | 2010 | 19873 | 0.030 |
Why?
|
| DNA Fragmentation | 2 | 2003 | 91 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 480 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2017 | 874 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 93 | 0.020 |
Why?
|
| Monensin | 1 | 2008 | 4 | 0.020 |
Why?
|
| Staurosporine | 1 | 2008 | 35 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 16 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 44 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 71 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 170 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 185 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2008 | 143 | 0.020 |
Why?
|
| Diglycerides | 1 | 2005 | 10 | 0.020 |
Why?
|
| Phospholipases | 1 | 2005 | 8 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 34 | 0.020 |
Why?
|
| Comet Assay | 1 | 2005 | 72 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2005 | 213 | 0.020 |
Why?
|
| Magnesium | 1 | 2005 | 95 | 0.020 |
Why?
|
| Receptors, Estradiol | 1 | 2003 | 2 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 229 | 0.010 |
Why?
|
| K562 Cells | 1 | 2003 | 31 | 0.010 |
Why?
|
| U937 Cells | 1 | 2003 | 27 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2003 | 32 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2003 | 105 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 420 | 0.010 |
Why?
|
| Osteoblasts | 1 | 2003 | 33 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 37 | 0.010 |
Why?
|
| Reference Values | 1 | 2003 | 204 | 0.010 |
Why?
|
| Receptors, Progesterone | 1 | 2003 | 78 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 445 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 296 | 0.010 |
Why?
|
| Deferoxamine | 1 | 2001 | 19 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 48 | 0.010 |
Why?
|
| Heme Oxygenase-1 | 1 | 2001 | 46 | 0.010 |
Why?
|
| RNA Probes | 1 | 2001 | 10 | 0.010 |
Why?
|
| Cold Temperature | 1 | 2001 | 39 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2001 | 59 | 0.010 |
Why?
|
| Ferritins | 1 | 2001 | 54 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 555 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2001 | 123 | 0.010 |
Why?
|
| Cell Size | 1 | 2001 | 42 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 84 | 0.010 |
Why?
|
| Drug Resistance | 1 | 2001 | 93 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 136 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 650 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2001 | 209 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1998 | 12 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 1998 | 7 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1998 | 30 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1998 | 33 | 0.010 |
Why?
|
| Nitric Oxide | 1 | 2001 | 287 | 0.010 |
Why?
|
| Proteins | 1 | 2001 | 352 | 0.010 |
Why?
|
| Pregnancy | 1 | 2003 | 1503 | 0.010 |
Why?
|
| Gene Expression | 1 | 2001 | 639 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2001 | 1442 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 1681 | 0.010 |
Why?
|
| Mice | 1 | 2001 | 5668 | 0.010 |
Why?
|
| Animals | 1 | 2001 | 14307 | 0.000 |
Why?
|